The European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study found that women with higher OPG serum levels had an increased relative risk (1.93) of developing estrogen receptor-negative (ER–) breast cancer [33]. This evidence concerns the gene ESR1 and breast carcinoma.